1. In vivo Induction of Resistance to Gemcitabine Results in Increased Expression of Ribonucleotide Reductase Subunit M1 as the Major Determinant
   Andries M. Bergman et al, 2005, Cancer Research CrossRef
2. The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
   Daniel R. Principe et al, 2021, Frontiers in Oncology CrossRef